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Abstract: Bisher wurde der osteoporotische Knochenverlust im ovariektomierten (OVX) Rattenmodel
mittels ex vivo Methoden evaluiert. Daher waren Sham-Tiere von Nöten. In dieser Studie wollte man
festellen, ob Knochenverlust im OVX Rattenmodel, bestimmt duch longitudinale in vivo Messugen mit-
tles peripherer quantitativer Computertomogaphy (pQCT), die gleichen Informationen liefert und ob
daher auf die Verwendung von Sham-Tieren verzichtet werden kann. Weiters wurden der mittels pQCT
gemessen Knochenverlust direkt verglichen mit konventionellen Micro-Computertomographischen (Micro-
CT) Auswertungen. Die Knochendichte (BMD) wurde am distalen Femur von einundzwanzig 12-wöchigen
Wistarratten mittels pQCT bestimmt. Danach wurden Tiere ovariektomiert oder Sham- operiert. Nach
weiteren 4 Wochen wurden die pQCT Messungen wiederholt und anschliessend die Tiere euthanasiert.
Mit Hife von Micro-CT Messungen wurden ex vivo BMD als auch BV/TV bestimmt. Die Resultate
haben gezeigt, dass innerhalb von 4 Wochen ein signifikanter Knochenwachstum herrscht. Wenn man
diesen miteinbezog, gab es keinen Unterschied zwischen dem Knochenverlust evaluiert mittels longitudi-
naler pQCT Messungen oder mit Hilfe einer Sham Gruppe (Micro-CT). Weiters konnten wir eine starke
lineare Korrelation zwischen BMD, gemessen mittels pQCT und BV/TV (%), erhalten durch Micro- CT
zeigen. Zusammenfassend kann behauptet werden, dass man auf Sham-Tiere verzichten kann, um den
Knochenverlust im OVX Rattenmodel bestimmen zu können, solange der Knochenwachstum bekannt
ist. Summary In the past, osteoporotic bone loss in the ovariectomised (OVX) rat model was monitored
with the use of ex vivo methods. Thus, sham animals were required. The purpose of this study was to
determine if bone loss in the OVX rat model monitored in an in vivo longitudinal fashion using the pe-
ripheral quantitative computed tomography (pQCT) provides the same information eliminating the use
of sham animals. Furthermore, parameters of bone loss measured with pQCT were directly compared to
that conventionally measured with the micro- computed tomography (micro-CT). Bone mineral density
(BMD) was measured at the distal femur of twenty-one 12 weeks old female Wistar rat with the pQCT.
Thereafter, animals were either OVX or sham operated, pQCT measurements were repeated 4 weeks
later and all rats were euthanized. Ex vivo BMD and BV/TV was measured with the use of micro-CT.
Results showed that there was significant growth during the 4 weeks and that taking this into account,
there was no difference between bone loss measured in a longitudinal fashion (pQCT) and that measured
in comparison to a sham group (micro-CT). In addition, we could demonstrate that there was a strong
linear correlation between BMD measured with pQCT and BV/TV (%) obtained from micro-CT. In
conclusion, there is no need to use sham animals for monitoring bone loss in the OVX rat model and
longitudinal pQCT measurements are sufficient, as long as the growth is known and adjusted for.
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Summary 
In the past, osteoporotic bone loss in the ovariectomised (OVX) rat model was monitored 
with the use of ex vivo methods. Thus, sham animals were required. The purpose of this study 
was to determine if bone loss in the OVX rat model monitored in an in vivo longitudinal 
fashion using the peripheral quantitative tomography (pQCT) provides the same information 
eliminating the use of sham animals. Furthermore, parameters of bone loss measured with 
pQCT were directly compared to that conventionally measured with the micro-computed 
tomography (micro-CT). Bone mineral density (BMD) was measured at the distal femur of 
twenty-one 12 weeks old female Wistar rat with the pQCT. Thereafter, animals were either 
OVX or sham operated, pQCT measurements were repeated 4 weeks later and all rats were 
euthanized. Ex vivo BMD and BV/TV was measured with the use of micro-CT. Results 
showed that there was significant growth during the 4 weeks and that taking this into account, 
there was no difference between bone loss measured in a longitudinal fashion (pQCT) and 
that measured in comparison to a sham group (micro-CT). In addition, we could demonstrate 
that there was a strong linear correlation between BMD measured with pQCT and BV/TV (%) 
obtained from micro-CT. In conclusion, there is no need to use sham animals for monitoring 
bone loss in the OVX rat model and longitudinal pQCT measurements are sufficient, as long 
as the growth is known and adjusted for.  
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Introduction 
 
Osteoporosis is a systemic skeletal disease characterized by low bone mass and 
microarchitectural deterioration of bone tissue with a consequent increase of bone fragility 
and susceptibility to fractures [1]. Amongst the elderly, osteoporosis is a problem with great 
morbidity and high mortality. For older women, the risk to die from a hip fracture [2] is 
nearly as high as to die from a stroke [3]. In addition, the increase in the elderly population 
will lead to an increased prevalence of osteoporosis and subsequent costs to society will rise. 
In order to study and develop surgical treatments of osteoporotic fractures as well as new 
strategies for pharmaceutical therapies, animal models of osteoporosis are needed [4]. The 
ovariectomised (OVX) rat is the most widely used animal model for osteoporosis [5,6] as it 
shares many similar characteristics to postmenopausal bone loss in women, e.g. bone 
resorption exceeding bone formation, greater loss of cancellous bone than cortical bone as 
well as similar treatment response to drugs like biphosphonates, estrogen, parathyroid 
hormones and calcitonin [7,8,9,10].  
 
To monitor bone loss in the OVX rat model conventional histology has been used in the past 
[11,12,13,14,15]. To overcome the limitations of histology, such as its manually intense 
nature, only two-dimensional morphometry and its destructive nature, the use of high-
resolution micro-computer tomography (micro-CT) has become more and more 
popular[16,17,18]. However, despite the possibility to quickly assess mineral density and 
three-dimensional microarchitecture from bone samples in a repeatable, non-destructive 
manner, a major disadvantage of standard micro-CT is that, similar to conventional histology, 
it is used ex vivo making it impossible to assess longitudinal temporal changes in the same 
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animal. This is, amongst others, the reason why studies using these ex vivo methods depend 
on the use of sham operated animals to confirm the bone loss after OVX [19,12,13,20].  
 
Peripheral computed tomography (pQCT) as well as a recently developed in vivo micro-CT 
(vivaCT40, Scanco Medical, Bassersdorf, Switzerland) is able to provide information from 
living animals in a longitudinal fashion. pQCT has been available for the detection of patients 
at high risk of osteoporosis. Serial examinations at different time points enable the 
individualisation of prophylaxis and treatment [21,22,23]. pQCT has been applied in rats 
[24,25,24,26], mice [27] and goats [28] for research purposes. Although the spatial resolution 
of the pQCT falls clearly short of that obtained by in vivo micro-CT, it provides a number of 
potential alternative advantages: (1) pQCT device can be used for patient assessment and for 
laboratory animals of different sizes, whereas in vivo micro-CT are limited to small 
laboratory animals; (2) although in vivo micro-CT offers a higher scanning speed than the 
previously developed micro-CT, depending on the resolution and sample size, the pQCT is 
normally still the faster system. This is important as the laboratory animals need to be 
anesthetized for the entire scanning duration and the longer the anesthesia, the burden for the 
animal in respect to its body circulation and inner body temperature regulation is increased; 
(3) radiation exposure is significantly lower in pQCT. The total radiation dose can be on the 
order of a few gray [29] with the use of in vivo micro-CT in typical longitudinal studies. The 
impact of radiation needs to be considered in such research, because intense radiation has 
been shown to have an effect on bone volume ratio [30].  
 
Micro-CT with its high resolution is the gold-standard for evaluation of bone mass and there 
are two different outcome-parameters available to describe it. BMD is a value calculated by 
the average of all gray-values in the defined region-of-interest (ROI) and is presented in the 
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unit milligram hydroxyapatite/cm3 (mg HA/cm3). BV/TV is the bone volume, which has been 
defined with a specific threshold, divided by the total volume-of-interest (VOI) in percent and 
it is the parameter most widely used. The parameter to describe bone mass in the pQCT 
without adding further steps of calculations is BMD.  
The question addressed in this work is whether bone loss in the osteoporotic rat model 
monitored in a longitudinal fashion (i.e. between the time of OVX and the beginning of the 
specific treatment) with the use of pQCT is similar to bone loss detected with micro-CT in 
comparison to a sham group so that sham animals could be avoided. Furthermore, in order to 
translate studies using pQCT measurements of bone density in the OVX rat model to those 
using micro-CT measurements, the correlations between pQCT BMD and micro-CT BV/TV 
was explored. 
 
Materials and Methods 
 
Animals  
Twenty-one 8 weeks old female Wistar rats (RCC, Basel, Switzerland) were acclimatised for 
four weeks, housed in Makro Type 4 cages in groups of four and fed with standard rodent 
chow (Provimi, Provimi Kliba AG, Kaiseraugst, Switzerland) and water ad libidum. At 12 
weeks of age, they were randomly divided into two groups: one group underwent bilateral 
ovariectomy (n=13, larger number for a subsequent study), while the other group received a 
sham operation (n=8). During the surgical procedures, animals were premedicated with 
buprenorphine (Temgesic®, Essex Chemie AG, Lucerne, Switzerland) and anesthetized with 
isoflurane (Isofluran Baxter ad us. vet.®, Baxter AG, Volketswil, Switzerland). 
Buprenorphine was given for two days post-operatively for analgesia. Each animal received a 
pQCT scan prior to surgical intervention; thereafter, they were kept under standard housing 
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conditions for four weeks to induce osteoporosis. The pQCT scan was repeated and then 
animals were euthanized by CO2 inhalation. The left femurs were harvested, freed from soft 
tissue and immediately fixed in 70% ethanol for high-resolution micro-CT. The procedure for 
animal care, experimental protocol and euthanasia in the study was approved by the Animal 
Experimentation Commission of the Veterinary Office of the Canton of Grison, Switzerland 
and followed the guidelines of the Swiss Federal Veterinary Office for the use and care of 
laboratory animals. 
 
pQCT  
pQCT was performed using 3D XtremeCT (Scanco Medical, Bassersdorf, Switzerland), 
which is used for patient examination[23] (Figure 1).  
 
 
 
 
 
 
 
Figure 1: Peripheral quantitative computed tomography (XtremeCT, Scanco Medical,      
Bassersdorf, Switzerland). 
 
This scanning system consists of a two-dimensional detector array with 3072x255 elements in 
combination with a microfocus X-Ray-tube having a spot size of 70 μm, enabling 
simultaneous acquisition of a stack of parallel CT slices. The rat was positioned on an in-
house custom made holder made of plexiglass, which allowed consistent and precise 
positioning of the rat leg (Figure 2). The longitudinal axis of the left leg was aligned 
perpendicular to the scanner beam. Fifty-three cross-sectional slices (corresponding to a 
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length of 2 mm) were collected at the distal femoral metaphysis with an isotropic voxel 
resolution of 41 μm and a pixel matrix of 3072x3072, using an effective energy of 60 keV and 
a current intensity of 900 μA. The total examination time was 10 minutes. The resulting gray-
scale images were then processed using a Gaussian low-pass filter (sigma=0.7; support=1) to 
 
remove noise, and apparent bone mineral density (BMD) was calculated.  
igure 2: In vivo analysis of distal rat femur with pQCT scanner using a plexiglass 
icro-CT 
 were also examined with a fan-beam micro-CT system (μCT40, Scanco Medical, 
F
holder. 
 
M
The femurs
Bassersdorf, Switzerland; Figure 3). This scanner was equipped with a microfocus X-ray tube 
(5-μm spot size) and a two-dimensional detector array with 2048x256 elements. The post-
mortem harvested left femur was placed longitudinally into a cylindrical holder with a 
diameter of 16 mm filled with 70% ethanol. Analogous to the pQCT measurements, the distal 
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femoral metaphysis was scanned, whereby in this case with a higher isotropic voxel resolution 
of 16 μm. One-hundred and thirty high-resolution slices (= 2 mm length, same length as 
chosen for the pQCT) with a pixel matrix of 2048x2048 were measured using an effective 
energy of 70 keV and a current intensity of 114 μA. After pre-processing the images with the 
same Gaussian filter (sigma=0.7; support=1), a threshold was selected at 28 % of the maximal 
gray scale value, which corresponds to the peak for bone tissue in the histogram of the gray 
value distribution in the image. BMD as well as BV/TV were evaluated. 
 
 
 
 
 
 
 
 
Figure 3: High-resolution micro-computed tomography (μCT 40, Scanco Medical, 
Bassersdorf, Switzerland) 
egion of interest (ROI) 
 the 2-mm-long ROI between pQCT and micro-CT measurements in 
 
R
For accurate matching of
the axial direction, an anatomical reference point was defined, which could easily be 
determined by visual inspection of both the micro-CT as well as the pQCT images (Figure 4). 
For each sample, the most proximal aspect of the distal femoral growth plate was chosen for 
this landmark. Analysis was performed for the total cross-sectional area (including cortical 
and trabecular bone; defined as “out”) as well as for trabecular bone only. For the selection of 
trabecular bone, two different algorithms were used. With the first algorithm the central 50% 
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cross-sectional area was defined based on an automatic contouring procedure available from 
the built-in computer software of the manufacturer (defined as “d50”). In the second 
algorithm, the trabecular region was precisely contoured in each single cross-section manually 
(defined as “man_in”).  
 
igure 4: a) The distal half of the rat femur as imaged with the micro-CT. The square 
plane indicates the distal most cross-section included in the ROI. b) The corresponding 
tatistics 
ere carried out using SPSS software (SPSS Science, 14.0 for Windows Chicago, 
a)  
 
 
 
 
 
 
 
 
 
F
pQCT cross-section image taken at the distal most aspect of the analysed ROI and c) the 
corresponding micro-CT image. Note the difference in resolution. 
 
S
Analyses w
IL, USA) and the significance threshold of p<0.05 was applied. A paired samples t-test was 
used to detect differences between the baseline and the follow-up measurement of the sham 
group and to evaluate differences between values assessed using the d50 and man_in. Instead, 
a repeated measures general linear model to compare differences in bone loss obtained with 
out, d50 and man_in was applied. A Tukey HSD post-hoc test to examine differences within a 
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group was used.  An analysis of variance (ANOVA) was carried out to determine whether 
there were significant differences between bone loss measured in a longitudinal fashion 
(pQCT) versus the bone loss analysed with the use of a sham group (pQCT and micro-CT). If 
significant differences were detected, a Tukey HSD post-hoc test was used to examine direct 
inter-group differences. A linear regression was also applied to evaluate the correlation 
between pQCT and micro-CT measurements as well as between the automatic (i.e. d50) and 
the manually defined areas of interest (i.e. man_in).  
 
Results 
ll animals survived the entire study period. The mean bone changes in percent measured in a 
als was 11%, 
 
A
longitudinal fashion (pQCT) as well as with the use of a sham group (pQCT and micro-CT) 
are showed in figure 5. There was a significant increase in BMD from the baseline and 
follow-up pQCT in the sham animals in all measured ROIs (out= 10.3%, p=0.000; d50= 
11.2%, p=0.001; man_in= 9.9%, p=0.007), as a consequence of bone growth.  
The BMD loss between the baseline and follow-up pQCT in the OVX anim
35.1%, 32.1% for out, d50 and man_in, respectively. This was in contrast to bone loss 
measured between OVX and sham animals with the pQCT in terms of BMD (20%, 42%, 
37.9%), with the micro-CT in terms of BMD (21.3%, 40.5%, 36,0%) and with the micro-CT 
in terms of BV/TV (22,5%, --, 44,5%; d50, an algorithm provided by the manufacturer does 
not include calculation of BV/TV). As the bone loss between the baseline and follow-up 
pQCT in the OVX animals does not take into account the significant normal bone growth 
detected in the longitudinal measurements of the sham animals, the longitudinal OVX bone 
loss was adjusted by adding the mean bone growth of the sham animals. No significant 
differences were detected between the “growth-corrected” longitudinal bone loss of the OVX 
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animals (pQCT/BMD) in comparison to bone loss measured with the help of sham animals 
(pQCT/BMD, micro-CT/BMD and micro-CT/(BV/TV) in any of the characterised ROI (out: 
p=0.492; d50: p=0.312; man_in: p=0.126, Figure 6).  
 
 
Figure 5: Experimental design and relative bone quality changes. The relative changes 
r the different ROIs are expressed as paired or independent mean changes ± S.D. All fo
parameters are BMD unless labelled differently. The time in weeks is the age of the rats. 
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Figure 6: Post-ovariectomy bone loss as calculated by various methods, in percent: mean 
± S.D. The bars are grouped according to imaging machine type and parameter as well 
as comparison type (blue = out, red = d50, yellow = man_in). pQCT (BMD) preOVX-
OVX has been growth adjusted.  
 
 
The BMD values obtained from high-resolution micro-CT measurements showed a strong 
correlation with those measured by lower-resolution pQCT (out: R2=0.99, p=0.000; d50: 
R2=0.96, p=0.000; man_in: R2=0.95, p=0.000). The slope of the correlation curve was slightly 
lower for out (0.82) than for d50 (0.93) and man_in (0.93) (Figure 7). Moreover, BV/TV 
measured with micro-CT also correlated positively with BMD measured by the pQCT (out: 
R2=0.96, p=0.000; man_in: R2=0.95, p=0.000) (Figure 8).  
As expected, the osteoporotic bone loss was always significantly more pronounced when 
analysing the trabecular region only (d50, man_in) than when examining the full cross-section 
(out) (p=0.000). There was also a significant difference in the evaluation of the trabecular 
region using d50 or man_in (p=0.000) with man_in exceeding d50 measurements. However, 
data showed a strong correlation to each other (R2=0.98, p=0.000). 
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Figure 7: Correlation between micro-CT (BMD) and pQCT (BMD); blue: out (R2= 0.99; 
y= 0.82+ 44.1); pink: d50 (R2= 0.99; y= 0.93- 1.1812); yellow: man_in (R2= 0.95; y= 0.93- 
9.29).  
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Figure 8: Correlation between micro-CT (BV/TV %) and pQCT (BMD); blue: out (R2= 
0.96); yellow: man_in (R2= 0.95).  
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Discussion 
 
The OVX rat is a well described model for osteoporosis [7,4]. In the past, osteoporotic bone 
loss was monitored with the use of ex-vivo methods such as histology and micro-CT [31,32]. 
Sham animals were essential for the control of induced bone loss as well as to evaluate 
changes which may have been caused by applied treatment, e.g. biphosphonates or calcitonin. 
Fortunately in vivo systems such as in vivo micro-CT and pQCT are available nowadays to 
offer the advantage of longitudinal measurements of one and the same animal. Although in 
vivo micro-CT provides the highest resolution data, these systems are not readily available 
due to their high cost and limited use for only small animals. Furthermore, the radiation 
dosages required for high resolution imaging may affect the bone volume ratio when used 
repeatedly in a longitudinal fashion [30]. In contrast, the pQCT is more widely available 
because it can also be used for larger animals as well as clinically and the radiation dosages 
are up to one-hundred-fold smaller [33]. The main difference between these two systems is 
the resolution of the image set. Although it was shown in studies using other animal models 
(mouse and goat) [28,27] or in a study using human specimen [34] that there is a good 
correlation between data received from the micro-CT and pQCT, it was not known for the 
OVX rat model whether the resolution differences would allow the bone loss to be monitored 
in a longitudinal fashion, eliminating the need to use sham animals.  
 
The findings of this study indicate that bone loss monitored longitudinally and in vivo by 
pQCT corresponds to bone loss measured by high-resolution micro-CT using a sham group of 
the same age for comparison. The only difference between OVX induced bone loss measured 
in a longitudinal fashion to bone loss detected in a comparative way to a sham group is 
represented by the factor “growth” which we evaluated with longitudinal measurements of the 
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sham animals. The same outcome was observed in each defined ROI (out, d50 or man_in) and 
was also true for different outcome parameters (pQCT BMD, micro-CT BMD and BV/TV). 
By adding the amount of bone growth to the bone loss measured longitudinally in the OVX 
group, the growth adjusted bone loss was not different to that measured in comparison to 
sham operated animals (figure 6). Moreover, the calculated values for BMD and BV/TV also 
correlated very closely. Therefore, in the future, the use of sham animals in the OVX rat 
model can be avoided when the animals growth rate is known. If normal bone changes are not 
expected during the duration of the experiment, this additional adjustment is probably not 
required. This finding is especially important for this particular rat model as there are many 
studies in which several time points are needed to evaluate changes induced by a specific 
treatment. With increased number of time-points, more animals are needed to improve the 
power of the analysis. This is true for bone of the treated and the untreated or sham control 
groups. Hence, we hope that now only one group of animals is actually needed independent 
on how many time-points are of interest and the large number of rats used in such studies can 
be substantially reduced.  
 
In the literature, bone loss in the OVX rat model has been measured via the gold-standards of 
micro-CT [17] or histologically [13] in terms of BV/TV. Previous studies demonstrated in 
other animal models (mouse and goat) [28,27] and human [34] specimens that there is a good 
correlation between micro-CT and pQCT evaluations of bone density. The results of our study 
showed that this is also true for the OVX rat model. There was a strong correlation (R2 > 
0.95) between the two machines, independent from the chosen correlation parameter. When 
looking at only the trabecular region, there was even a stronger correlation (R2 > 0.95) 
compared to the results of a goat study with an R2 of 0.7 [28]. The reason for this is probably 
the more accurate and very consistent definition of the region of interest in our study whereby 
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the exact same volume size and location were chosen. It can be generally said that bone 
density measured with pQCT will always provide slightly different values than obtained with 
micro-CT because effective energy, current intensity as well as calibration files are device-
dependent. The offset resulting in the correlation between BV/TV and BMD is due to the 
background density of bone marrow, which is not reflected when calculating bone ratio based 
on a segmentation threshold. However, there is a strong correlation between the two machines 
and the resulting percentual bone loss will be equal.  
 
Bone density values of the trabecular region evaluated with man_in significantly exceeded 
d50 values. This is due to the fact that with manual contouring the entire trabecular region 
was precisely selected, while the automatic procedure selected a smaller central area within 
the trabecular region. This can become an issue when the ROI is adjacent to the formation of 
the medullary canal where endosteal bone thinning has a stronger effect. However, the two 
evaluation systems showed again a very strong relation to each other (R2=0.98), which makes 
both systems appropriate for the evaluation of bone loss in the trabecular bone region. The 
advantage of d50 is that being a full-automatic procedure, it is less labor intensive and can 
clearly be faster than the man_in definition.  
 
According to the literature, osteoporotic bone loss was more pronounced in the trabecular 
region than in the cortical region in this study [35,36]. Moreover, the detected bone loss in the 
trabecular region of approximately 40 % within 4 weeks in this specific model stands in good 
agreement to previous publications (figure 5) [17].  
In conclusion, this study showed that it is possible to eliminate the use of sham animals to 
monitor bone loss in the OVX rat model when using longitudinal pQCT measurements, as 
long as bone quality changes due to growth is known and adjusted for. The strong correlation 
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between BMD measured with pQCT and BMD as well as BV/TV (%) obtained from micro-
CT was confirmed in OVX rat bones. pQCT appears to be an accurate tool to measure bone 
loss (%) in the OVX rat model offering the same information than the gold-standard micro-
CT.  
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